GlassScriptPhysician profile
Andreia N Barbieri
NPI 1215315619
$513.26
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $70.58 · 2021: $25.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $195.83 | 2019-2021 | |
| Celgene Corporation | $77.50 | 2019-2020 | |
| Incyte Corporation | $43.41 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.97 | 2019 | |
| Alexion Pharmaceuticals, INC. | $31.82 | 2019 | |
| Agios Pharmaceuticals, INC. | $29.25 | 2019 | |
| Amgen INC. | $25.32 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.00 | 2019 | |
| Rigel Pharmaceuticals, INC. | $16.05 | 2019 | |
| Dova Pharmaceuticals | $13.81 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.65 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreia Barbieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.